Showing results (51-60 of 250) with videos related to
Sort By:
Pageof 25
Diagnostics (Basel, Switzerland)|March 25, 2022
Multichamber Involvement of Metastatic Cardiac MelanomaMaria S Bonou, Panagiotis Diamantopoulos, Sofia Mavrogeni, et al.Experimental and Therapeutic Medicine|December 23, 2022
Diabetes insipidus: A rare endocrine complication of immune check point inhibitors: A case report and literature reviewAnna Angelousi, Petros Papalexis, Athina Karampela, et al.Cancer Medicine|March 27, 2025
Exploring the Dynamics of Immune Checkpoint Inhibitor-Induced Eosinophilia in Advanced/Metastatic Melanoma: A Comprehensive Retrospective AnalysisPanagiotis T Diamantopoulos, Aikaterini Gkoufa, Amalia Anastasopoulou, et al.Melanoma Research|September 8, 2020
Concomitant development of neurologic and cardiac immune-related adverse effects in patients treated with immune checkpoint inhibitors for melanomaPanagiotis T Diamantopoulos, Katerina Tsatsou, Olga Benopoulou, et al.Cancers|January 11, 2024
COVID-19 in Patients with Melanoma: A Single-Institution StudyAmalia Anastasopoulou, Panagiotis T Diamantopoulos, Panagiotis Kouzis, et al.Diseases (Basel, Switzerland)|February 23, 2024
Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic CriteriaAnna Angelousi, Dimitrios C Ziogas, Vasiliki Siampanopoulou, et al.Current Oncology (Toronto, Ont.)|May 26, 2026
Overlapping Toxicities of Pembrolizumab and Lenvatinib: A Case of Capillary Leak Syndrome with Severe ErythroblastosisAikaterini Gkoufa, Iraklis Patsialos, Christos Stafylidis, et al.The Oncologist|May 11, 2019
A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway InhibitorsClio Dessinioti, Mikaella Plaka, Efthymia Soura, et al.Current Oncology Reports|February 5, 2026
Toward Microbiome-Informed Melanoma Care: The Gut Microbiota in Melanoma Evolution, Immunotherapy Response and Immune-Related ToxicityDimitrios C Ziogas, Charalampos Theocharopoulos, Anastasios Martinos, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 10, 2025
Bone mineral density changes following immune checkpoint inhibitor therapy: insights from a case series analysisVasiliki Siampanopoulou, Dimitrios C Ziogas, George Lyrarakis, et al.Pageof 25